oral glp-1 for weight loss FDA Approves Semaglutide as the First Oral Pill? No injections Oral GLP-1 Troche — Needle-Free
Description
Concurrently, the Low Glycemic Index Treatment (LGIT), developed by Pfeifer and Thiele (2005), allows 4060 g of carbohydrates per day with a glycemic index below 50, achieving greater than 90% seizure reduction in 50% of patients in their initial series [97]
ArticlePubMed 83
The REWIND trial (dulaglutide) found acute pancreatitis in 0.5% of dulaglutide patients versus 0.4% of placebo patients
Recent studies have indicated that GLP-1RAs may possess neuroprotective properties (12) and directly reduce ICP
